By  on January 7, 2019

While consulting on a sun-care product two years ago, Sylvie Giret hit upon a paradox. Despite the fact sun protection product sales were escalating, so were cases of skin cancer.

Just released projections from Technavio forecast the global non-melanoma skin cancer market — the most common form — will expand at a compound annual growth rate close to 6 percent through 2022.

To continue reading this article...

load comments
blog comments powered by Disqus